Is PCSK9 Associated with Plasma Lipid Levels in a Sub-Saharan African Population of Patients with Obesity and Type 2 Diabetes?

Camille Maadjhou MbaWilfred MbachamEugène SobngwiJean Claude Mbanya

Published in: Diabetes, metabolic syndrome and obesity : targets and therapy (2019)

Obese and type 2 diabetes subjects have higher PCSK9 levels when compared to lean controls, suggesting that these metabolic states potentially impact PCSK9 levels in Cameroonian patients.

Keyphrases

type diabetes
insulin resistance
metabolic syndrome
weight loss
end stage renal disease
glycemic control
newly diagnosed
ejection fraction
cardiovascular disease
adipose tissue
low density lipoprotein
patient reported outcomes